ECZEMA ATOPIC DERMATITIS
Clinical trials for ECZEMA ATOPIC DERMATITIS explained in plain language.
Never miss a new study
Get alerted when new ECZEMA ATOPIC DERMATITIS trials appear
Sign up with your email to follow new studies for ECZEMA ATOPIC DERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Baby probiotic trial aims to stop colic before it starts
Prevention Recruiting nowThis study tests whether a daily probiotic supplement (L. reuteri) given to healthy newborns can prevent colic and excessive crying. Researchers will compare babies who get the probiotic to those who get a placebo, tracking crying time and digestive health over the first 3 months…
Matched conditions: ECZEMA ATOPIC DERMATITIS
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Prevention
Last updated May 26, 2026 09:37 UTC
-
New eczema drug shows promise in Mid-Stage trial
Symptom relief Recruiting nowThis study tests a new medicine called camoteskimab for adults with moderate-to-severe atopic dermatitis (eczema). About 280 people will receive either the drug or a placebo to see if it reduces skin redness, swelling, and itching. The main goal is to measure improvement in eczem…
Matched conditions: ECZEMA ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Apollo Therapeutics Ltd • Aim: Symptom relief
Last updated May 26, 2026 09:36 UTC
-
Natural oil takes on steroids for itchy ear condition
Symptom relief Recruiting nowThis study tests whether black seed oil can safely reduce itching, pain, and inflammation from ear eczema, compared to standard steroid ear drops. About 85 adults will use either the oil or the drops for 10 days. The goal is to find a natural alternative with fewer side effects.
Matched conditions: ECZEMA ATOPIC DERMATITIS
Phase: NA • Sponsor: Bezmialem Vakif University • Aim: Symptom relief
Last updated May 26, 2026 09:28 UTC
-
New eczema ointment shows promise in Mid-Stage trial
Symptom relief Recruiting nowThis study tests an experimental ointment called GX-03 in adults with moderate to severe eczema. About 110 participants will apply either GX-03 or a placebo cream daily for 8 weeks. Researchers will check if the treatment clears skin, reduces itch, and improves quality of life.
Matched conditions: ECZEMA ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Turn Therapeutics • Aim: Symptom relief
Last updated May 22, 2026 13:53 UTC